UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study

The Lancet (British edition), 2011-10, Vol.378 (9800), p.1396-1407

2011

Volltextzugriff (PDF)

Bone disease and skeletal complications in patients with β thalassemia major

Bone (New York, N.Y.), 2011-03, Vol.48 (3), p.425-432

2011

Volltextzugriff (PDF)

How I treat transfusional iron overload

Blood, 2012-11, Vol.120 (18), p.3657-3669

2012

Volltextzugriff (PDF)

Optimal management of β thalassaemia intermedia

British journal of haematology, 2011-03, Vol.152 (5), p.512-523

2011

Volltextzugriff (PDF)

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

Haematologica (Roma), 2011-11, Vol.96 (11), p.1605-1612

2011

Volltextzugriff (PDF)

Mechanisms of Renal Disease in β-Thalassemia

Journal of the American Society of Nephrology, 2012-08, Vol.23 (8), p.1299-1302

2012

Volltextzugriff (PDF)

Thalidomide and thrombosis. A meta-analysis

Thrombosis and haemostasis, 2007-06, Vol.97 (6), p.1031-1036

2007

Volltextzugriff (PDF)

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

Blood, 2010-03, Vol.115 (10), p.1886-1892

2010

Volltextzugriff (PDF)

Cerebral infarction in β-thalassemia intermedia: Breaking the silence

Thrombosis research, 2012-11, Vol.130 (5), p.695-702

2012

Volltextzugriff (PDF)

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study

Blood, 2012-08, Vol.120 (5), p.970-977

2012

Volltextzugriff (PDF)

Management of Non-Transfusion-Dependent Thalassemia: A Practical Guide

Drugs (New York, N.Y.), 2014-10, Vol.74 (15), p.1719-1729

2014

Volltextzugriff (PDF)

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia

Blood, 2012-01, Vol.119 (2), p.364-367

2012

Volltextzugriff (PDF)

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Haematologica (Roma), 2010-04, Vol.95 (4), p.557-566

2010

Volltextzugriff (PDF)

Hematological manifestations of celiac disease

Scandinavian journal of gastroenterology, 2012-12, Vol.47 (12), p.1401-1411

2012

Volltextzugriff (PDF)

Age‐related complications in treatment‐naïve patients with thalassaemia intermedia

British journal of haematology, 2010-08, Vol.150 (4), p.486-489

2010

Volltextzugriff (PDF)

The Spine in β-Thalassemia Syndromes

Spine (Philadelphia, Pa. 1976), 2012-02, Vol.37 (4), p.334-339

2012

Volltextzugriff (PDF)

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

Thrombosis and haemostasis, 2006-10, Vol.96 (4), p.488-491

2006

Volltextzugriff (PDF)

The Hematologic Manifestations of the Antiphospholipid Syndrome

Blood reviews, 2008-07, Vol.22 (4), p.187-194

2008

Volltextzugriff (PDF)

Thalassemia and hypercoagulability

Blood reviews, 2008-09, Vol.22 (5), p.283-292

2008

Volltextzugriff (PDF)

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with β-thalassemia major

Haematologica (Roma), 2012-06, Vol.97 (6), p.842-848

2012

Volltextzugriff (PDF)

Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion‐independent thalassemia intermedia compared to regularly transfused thalassemia major patients

American journal of hematology, 2010-04, Vol.85 (4), p.288-290

2010

Volltextzugriff (PDF)

Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy

Thrombosis research, 2009-03, Vol.123 (5), p.679-686

2009

Volltextzugriff (PDF)

Continued improvement in myocardial T2 over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

Haematologica (Roma), 2011-01, Vol.96 (1), p.48-54

2011

Volltextzugriff (PDF)

PVC membrane and coated graphite potentiometric sensors based on 1-phenyl-3-pyridin-2-yl-thiourea for selective determination of iron(III)

Electrochimica acta, 2010-09, Vol.55 (22), p.6724-6730

2010

Volltextzugriff (PDF)

Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia

Haematologica (Roma), 2008-06, Vol.93 (6), p.941-942

2008

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(95)
Humans
(85)
Science & Technology
(82)
Life Sciences & Biomedicine
(81)
Hematologic And Hematopoietic Diseases
(61)
Male
(55)
Female
(53)
Adult
(47)
Hematology
(42)
Anemias. Hemoglobinopathies
(41)
Diseases Of Red Blood Cells
(41)
Middle Aged
(32)
Adolescent
(30)
Child
(23)
Young Adult
(17)
Metabolic Diseases
(16)
Metals
(16)
Other Metabolic Disorders
(16)
Aged
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study

Bone disease and skeletal complications in patients with β thalassemia major

How I treat transfusional iron overload

Optimal management of β thalassaemia intermedia

Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

Mechanisms of Renal Disease in β-Thalassemia

Thalidomide and thrombosis. A meta-analysis

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

Cerebral infarction in β-thalassemia intermedia: Breaking the silence

Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study

Management of Non-Transfusion-Dependent Thalassemia: A Practical Guide

Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Hematological manifestations of celiac disease

Age‐related complications in treatment‐naïve patients with thalassaemia intermedia

The Spine in β-Thalassemia Syndromes

Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

The Hematologic Manifestations of the Antiphospholipid Syndrome

Thalassemia and hypercoagulability

Deferasirox for up to 3 years leads to continued improvement of myocardial T2 in patients with β-thalassemia major

Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion‐independent thalassemia intermedia compared to regularly transfused thalassemia major patients

Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy

Continued improvement in myocardial T2 over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

PVC membrane and coated graphite potentiometric sensors based on 1-phenyl-3-pyridin-2-yl-thiourea for selective determination of iron(III)

Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia

Aktive Filter

Suchergebnisse filtern